BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 16522501)

  • 21. Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT).
    Ward JI; Cherry JD; Chang SJ; Partridge S; Keitel W; Edwards K; Lee M; Treanor J; Greenberg DP; Barenkamp S; Bernstein DI; Edelman R;
    Clin Infect Dis; 2006 Jul; 43(2):151-7. PubMed ID: 16779740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rationale for use of Tdap booster vaccines for adolescent immunization: overview of efficacy, safety, and clinical use.
    Hitchcock WP
    Clin Pediatr (Phila); 2006 Nov; 45(9):785-94. PubMed ID: 17041165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on pertussis in children.
    Heininger U
    Expert Rev Anti Infect Ther; 2010 Feb; 8(2):163-73. PubMed ID: 20109046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acellular pertussis vaccines: a turning point in infant and adolescent vaccination.
    Rappuoli R
    Infect Agents Dis; 1996 Jan; 5(1):21-8. PubMed ID: 8789596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen.
    Mooi FR
    Infect Genet Evol; 2010 Jan; 10(1):36-49. PubMed ID: 19879977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A countywide outbreak of pertussis: initial transmission in a high school weight room with subsequent substantial impact on adolescents and adults.
    Sotir MJ; Cappozzo DL; Warshauer DM; Schmidt CE; Monson TA; Berg JL; Zastrow JA; Gabor GW; Davis JP
    Arch Pediatr Adolesc Med; 2008 Jan; 162(1):79-85. PubMed ID: 18180417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Why still whooping cough?].
    Guiso N
    Rev Prat; 2005 Jun; 55(12):1287-92. PubMed ID: 16138592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re-emergence of pertussis: what are the solutions?
    Libster R; Edwards KM
    Expert Rev Vaccines; 2012 Nov; 11(11):1331-46. PubMed ID: 23249233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Time for booster doses against whooping cough for 10-year-old children].
    Carlsson RM; Ekholm L; Gothefors L; Granström M; Trolin I; Tegnell A
    Lakartidningen; 2005 Aug 29-Sep 4; 102(35):2394-8. PubMed ID: 16184889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands.
    de Greeff SC; Mooi FR; Schellekens JF; de Melker HE
    Pediatr Infect Dis J; 2008 Mar; 27(3):218-23. PubMed ID: 18277916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A "new age" in pertussis prevention new opportunities through adult vaccination.
    Cortese MM; Baughman AL; Brown K; Srivastava P
    Am J Prev Med; 2007 Mar; 32(3):177-185. PubMed ID: 17296469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pertussis resurgence: diagnosis, treatment, prevention, and beyond.
    Raguckas SE; VandenBussche HL; Jacobs C; Klepser ME
    Pharmacotherapy; 2007 Jan; 27(1):41-52. PubMed ID: 17192161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiological and immunological reasons for pertussis vaccination in adolescents and adults.
    Nitsch-Osuch A; Korzeniewski K; Kuchar E; Zielonka T; Życińska K; Wardyn K
    Respir Physiol Neurobiol; 2013 Jun; 187(1):99-103. PubMed ID: 23419520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria.
    Rendi-Wagner P; Paulke-Korinek M; Stanek G; Khanakah G; Kollaritsch H
    Pediatr Infect Dis J; 2007 Sep; 26(9):806-10. PubMed ID: 17721375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pertussis in adolescents and adults: time to reimmunize?
    Keitel WA; Edwards KM
    Semin Respir Infect; 1995 Mar; 10(1):51-7. PubMed ID: 7761714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal pertussis is hazardous for a newborn: a case report.
    Armangil D; Tekinalp G; Yurdakök M; Yalçin E
    Turk J Pediatr; 2010; 52(2):206-10. PubMed ID: 20560262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lifelong protection against pertussis].
    Riffelmann M; Wirsing von König CH
    Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S86-9. PubMed ID: 19353478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pertussis: review of epidemiology, diagnosis, management and prevention.
    Wood N; McIntyre P
    Paediatr Respir Rev; 2008 Sep; 9(3):201-11; quiz 211-2. PubMed ID: 18694712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis.
    Purdy KW; Hay JW; Botteman MF; Ward JI
    Clin Infect Dis; 2004 Jul; 39(1):20-8. PubMed ID: 15206048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are vaccination programs and isolate polymorphism linked to pertussis re-emergence?
    Godfroid F; Denoël P; Poolman J
    Expert Rev Vaccines; 2005 Oct; 4(5):757-78. PubMed ID: 16221076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.